(Total Views: 1205)
Posted On: 05/13/2024 1:00:48 AM
Post# of 148878
Longer-acting LL 1 yr ago:
"We are also developing a longer acting version of Leronlimab with our partners at Oregon Health and Science University. It has been tested in animal models, including rhesus monkeys, and has been shown to remain active inside the body for up to 180 days, treated monkeys are highly resistant to HIV infection, even after repeat challenges on a weekly basis for months. These data are really exciting, and there is no reason this long-acting version cannot also be used for the treatment of solid tumors and Nash"
_____
180 days & repeated testing?
Wow
1 yr is the Provisional Patent window before needing to have filed the full Patent application.
I'd keep an eye out for OSHU filing the Patent.
Assignee being Cytodyn.
Shall see....
"We are also developing a longer acting version of Leronlimab with our partners at Oregon Health and Science University. It has been tested in animal models, including rhesus monkeys, and has been shown to remain active inside the body for up to 180 days, treated monkeys are highly resistant to HIV infection, even after repeat challenges on a weekly basis for months. These data are really exciting, and there is no reason this long-acting version cannot also be used for the treatment of solid tumors and Nash"
_____
180 days & repeated testing?
Wow
1 yr is the Provisional Patent window before needing to have filed the full Patent application.
I'd keep an eye out for OSHU filing the Patent.
Assignee being Cytodyn.
Shall see....
(9)
(0)Scroll down for more posts ▼
